SrasV1, Main, Exploration, bibRecord, 005273

Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003

Identifieur interne : 005273 ( Main/Exploration ); précédent : 005272; suivant : 005274

Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003

Auteurs : Hoe-Nam Leong ; Brenda Ang ; Arul Earnest ; Cindy Teoh ; Wei Xu ; Yee-Sin Leo

Source :

Tropical Medicine & International Health [ 1360-2276 ] ; 2004.

RBID : PMC:7169743

Abstract

Summary

Objective Ribavirin is a broad spectrum nucleoside analogue efficacious in the treatment of several viral infections. In the recent severe acute respiratory syndrome (SARS) outbreak, ribavirin was used in various countries against this novel coronavirus. We conducted a retrospective analysis to assess the efficacy of ribavirin in the treatment of SARS in Singapore.

Methods A total of 229 cases were analysed. Ninety‐seven (42.4%) patients received ribavirin at a mean of 6.4 days of illness. Clinical and laboratory parameters taken at the start of ribavirin treatment were compared with day 5, 6 or 7 parameters of those patients not on treatment. The two groups were compared using Fisher's exact test and Student's t‐test. Multivariate analysis was performed using Cox regression model with death as the outcome of interest.

Results The treatment group had younger women with more symptoms of myalgia (P < 0.001). The crude death rate was 12.9% in the control and 10.3% (P = 0.679) in the treatment group. After correction for age, male sex, lactate dehydrogenase levels and steroid use, the hazard ratio was 1.03 (95% CI: 0.44–2.41, P = 0.939).

Conclusion In this retrospective, uncontrolled cohort analysis, use of ribavirin did not appear to confer any benefit for patients with SARS.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169743

DOI: 10.1111/j.1365-3156.2004.01281.x
PubMed: NONE
PubMed Central: 7169743

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003</title>
<author><name sortKey="Leong, Hoe Am" sort="Leong, Hoe Am" uniqKey="Leong H" first="Hoe-Nam" last="Leong">Hoe-Nam Leong</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ang, Brenda" sort="Ang, Brenda" uniqKey="Ang B" first="Brenda" last="Ang">Brenda Ang</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Earnest, Arul" sort="Earnest, Arul" uniqKey="Earnest A" first="Arul" last="Earnest">Arul Earnest</name>
<affiliation><nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Teoh, Cindy" sort="Teoh, Cindy" uniqKey="Teoh C" first="Cindy" last="Teoh">Cindy Teoh</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Xu, Wei" sort="Xu, Wei" uniqKey="Xu W" first="Wei" last="Xu">Wei Xu</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Leo, Yee In" sort="Leo, Yee In" uniqKey="Leo Y" first="Yee-Sin" last="Leo">Yee-Sin Leo</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmc">7169743</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169743</idno>
<idno type="RBID">PMC:7169743</idno>
<idno type="doi">10.1111/j.1365-3156.2004.01281.x</idno>
<idno type="pmid">NONE</idno>
<date when="2004">2004</date>
<idno type="wicri:Area/Pmc/Corpus">001520</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001520</idno>
<idno type="wicri:Area/Pmc/Curation">001520</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001520</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001616</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001616</idno>
<idno type="wicri:Area/Ncbi/Merge">003F00</idno>
<idno type="wicri:Area/Ncbi/Curation">003F00</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003F00</idno>
<idno type="wicri:doubleKey">1360-2276:2004:Leong H:investigational:use:of</idno>
<idno type="wicri:Area/Main/Merge">005672</idno>
<idno type="wicri:Area/Main/Curation">005273</idno>
<idno type="wicri:Area/Main/Exploration">005273</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003</title>
<author><name sortKey="Leong, Hoe Am" sort="Leong, Hoe Am" uniqKey="Leong H" first="Hoe-Nam" last="Leong">Hoe-Nam Leong</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Ang, Brenda" sort="Ang, Brenda" uniqKey="Ang B" first="Brenda" last="Ang">Brenda Ang</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Earnest, Arul" sort="Earnest, Arul" uniqKey="Earnest A" first="Arul" last="Earnest">Arul Earnest</name>
<affiliation><nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Teoh, Cindy" sort="Teoh, Cindy" uniqKey="Teoh C" first="Cindy" last="Teoh">Cindy Teoh</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Xu, Wei" sort="Xu, Wei" uniqKey="Xu W" first="Wei" last="Xu">Wei Xu</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Leo, Yee In" sort="Leo, Yee In" uniqKey="Leo Y" first="Yee-Sin" last="Leo">Yee-Sin Leo</name>
<affiliation><nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Tropical Medicine & International Health</title>
<idno type="ISSN">1360-2276</idno>
<idno type="eISSN">1365-3156</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><title>Summary</title>
<p><bold>Objective </bold>
 Ribavirin is a broad spectrum nucleoside analogue efficacious in the treatment of several viral infections. In the recent severe acute respiratory syndrome (SARS) outbreak, ribavirin was used in various countries against this novel coronavirus. We conducted a retrospective analysis to assess the efficacy of ribavirin in the treatment of SARS in Singapore.</p>
<p><bold>Methods </bold>
 A total of 229 cases were analysed. Ninety‐seven (42.4%) patients received ribavirin at a mean of 6.4 days of illness. Clinical and laboratory parameters taken at the start of ribavirin treatment were compared with day 5, 6 or 7 parameters of those patients not on treatment. The two groups were compared using Fisher's exact test and Student's <italic>t</italic>
‐test. Multivariate analysis was performed using Cox regression model with death as the outcome of interest.</p>
<p><bold>Results </bold>
 The treatment group had younger women with more symptoms of myalgia (<italic>P</italic>
 < 0.001). The crude death rate was 12.9% in the control and 10.3% (<italic>P</italic>
 = 0.679) in the treatment group. After correction for age, male sex, lactate dehydrogenase levels and steroid use, the hazard ratio was 1.03 (95% CI: 0.44–2.41, <italic>P</italic>
 = 0.939).</p>
<p><bold>Conclusion </bold>
 In this retrospective, uncontrolled cohort analysis, use of ribavirin did not appear to confer any benefit for patients with SARS.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Ang, Brenda" sort="Ang, Brenda" uniqKey="Ang B" first="Brenda" last="Ang">Brenda Ang</name>
<name sortKey="Earnest, Arul" sort="Earnest, Arul" uniqKey="Earnest A" first="Arul" last="Earnest">Arul Earnest</name>
<name sortKey="Leo, Yee In" sort="Leo, Yee In" uniqKey="Leo Y" first="Yee-Sin" last="Leo">Yee-Sin Leo</name>
<name sortKey="Leong, Hoe Am" sort="Leong, Hoe Am" uniqKey="Leong H" first="Hoe-Nam" last="Leong">Hoe-Nam Leong</name>
<name sortKey="Teoh, Cindy" sort="Teoh, Cindy" uniqKey="Teoh C" first="Cindy" last="Teoh">Cindy Teoh</name>
<name sortKey="Xu, Wei" sort="Xu, Wei" uniqKey="Xu W" first="Wei" last="Xu">Wei Xu</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005273 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005273 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:7169743
   |texte=   Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:NONE" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

Serveur d'exploration SRAS

Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003

Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.